Position in INSM
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$312,813
-$835,891 QoQ
Shares Held
1,913
-83.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in INSM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026TWO SIGMA SECURITIES, LLC holds $9,836,446 across 97 Biotechnology names. INSM ranks #7 (3.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BMRN |
Biomarin Pharmaceutical Inc
|
22,096 | $1,248,203 | |
| 2 | INCY |
Incyte Corp
|
11,772 | $1,107,980 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,135 | $876,946 | |
| 4 | ABVX |
Abivax S.A.
|
3,936 | $438,273 | |
| 5 | SYRE |
Spyre Therapeutics, Inc.
|
6,851 | $345,564 | |
| 6 | TGTX |
Tg Therapeutics, Inc.
|
9,885 | $328,379 | |
| 7 | INSM |
INSMED Inc
This page
|
1,913 | $312,813 | |
| 8 | SNDX |
Syndax Pharmaceuticals Inc
|
13,009 | $303,890 |
All Filings in INSM
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $312,813 | 1,913 | Shares | Sole | 2026-05-15 | |
| 2025-06-30 | $1,148,704 | 11,414 | Shares | Sole | 2025-08-14 | |
| 2024-06-30 | $254,466 | 3,798 | Shares | Sole | 2024-08-14 | |
| No filing history on record for this holder in this stock. | ||||||